EP4017494
THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
21.8.2020:
20.8.2025:
20764910.4
:
20.8.2040:
19.12.2025
:
THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
21.8.2020
20.8.2025
19.12.2025
:
Neurocrine Biosciences, Inc.:
6027 Edgewood Bend Court, San Diego, CA 92130, US
:
LOEWEN, Gordon Raphael:
Solana Beach, California 92075, US
:
LUO, Sha Rosa:
San Diego, California 92130, US
:
201962890697 P:
23.8.2019:
US
:
202063028754 P:
22.5.2020:
US
:
US2020047392:
21.8.2020
:
A61K 31/4738, A61P 13/12, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/24, A61P 25/28, A61K 9/00